The Hearty Soul on MSN
This is why some people had blood clots from the COVID-19 vaccine and others didn't
Rare medical events draw intense attention during any mass vaccination campaign. Among COVID vaccine side effects, few ...
Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...
Kylie Quinn receives funding from RMIT University, the Rebecca L Cooper Foundation and the CASS Foundation. This week, US health authorities recommended pausing the rollout of the one-shot Johnson & ...
Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a rare clotting disorder that emerged in a small number of people who received ...
SHENZHEN, China, Nov. 19, 2021 /PRNewswire/ -- At 3 a.m. on November 19, the first batch of more than 4 million doses of adenovirus vector COVID-19 vaccines produced by Shenzhen Kangtai Biological ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Removing non-essential regions like E3 allows additional ...
AstraZeneca and the University of Oxford offered a promising but confusing early look at late-stage data for their experimental adenoviral vector vaccine for COVID-19. The preliminary results suggest ...
Researchers in the United States have developed adenovirus vectors that may be more effective at generating immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results